SCHEMBL7976579

SCHEMBL7976579

Cn1cc(C2=C(c3cn(C)c4cc(N5CCOCC5)ccc34)C(=O)NC2=O)c2ccc(Br)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 12/20 0.56
CDK2 P24941 4/20 0.51
CDK4 P11802 3/20 0.51
CCND1 P24385 3/20 0.51
CCNE2 O96020 2/20 0.51
CCNE1 P24864 2/20 0.51
CAMK2D Q13557 1/20 0.48
PRKCB P05771 5/20 0.47
PRKCA P17252 5/20 0.47
PRKCE Q02156 3/20 0.47
PRKCG P05129 6/20 0.47
PRKCD Q05655 1/20 0.46
CDK1 P06493 2/20 0.46
PRKCQ Q04759 1/20 0.46
CCNT1 O60563 1/20 0.46
CCNB1 P14635 1/20 0.46
CCND3 P30281 1/20 0.46
CDK9 P50750 1/20 0.46
CDK3 Q00526 1/20 0.46
CDK6 Q00534 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7529269 0.90 GSK3B (0.54) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7530443 0.88 GSK3B (0.72) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7977136 0.88 GSK3B (0.57) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7976147 0.87 GSK3B (0.56) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7976571 0.87 GSK3B (0.56) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7976484 0.85 GSK3B (0.54) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7526149 0.85 GSK3B (0.53) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7987080 0.85 GSK3B (0.54) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7976559 0.84 GSK3B (0.53) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL7990286 0.83 GSK3B (0.52) GSK3BCDK2CDK4CCND1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US claimed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed